Chelation therapy for coronary heart disease: An overview of all clinical investigations

American Heart Journal

Volumn 140, Issue 1, 2000, Pages 139-141

  Ernst, E ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EDETIC ACID;

ARTICLE; CHELATION THERAPY; DATA BASE; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; UNNECESSARY PROCEDURE;

EID: 0033928475     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2000.107548     Document Type: Article

References (37)

1. Ernst E. Chelation therapy for peripheral arterial occlusive disease. Circulation 1997;96:1031-3.
2. Lin J-L, Ho H-H, Yu C-C. Chelation therapy for patients with elevated body lead burden and progressive renal insufficiency. A randomized, controlled trial. Ann Intern Med 1999;130:7-13.
3. Chappell LT, Janson M. EDTA chelation therapy in the treatment of vascular disease. J Cardiovasc Nurs 1996;10:78-86.
4. Holmes NH. Chelation therapy. In: Nurse's handbook of alternative and complementary therapies. Springhouse; 1999. p. 378.
5. Grier MT, Meyers DG. So much writing, so little science: a review of 37 years of literature on edetate sodium chelation therapy. Ann Pharmacother 1993;27:1504-9.
6. Rathmann KL, Golightly LK. Chelation therapy of atherosclerosis. Drug Int Clin Pharm 1984;18:1000-3.
7. Chappell LT, Stahl JP. The correlation between EDTA chelation therapy and improvement in cardiovascular function: a meta-analysis. J Advancement Med 1993;6:139-60.
8. Clarke NE, Clarke CN, Mosher RE. The "in vivo" dissolution of metastatic calcium: an approach to atherosclerosis. Am J Med Sci 1955;229:142-9.
9. Clarke NE, Clarke CN, Mosher RE. Treatment of angina pectoris with disodium EDTA. Am J Med Sci 1956;232:654-66.
10. Boyle AJ, Jasper JJ, McCormick H. Studies in human and induced atherosclerosis employing EDTA. Bull Schw Akad Wiss 1957;13:408-25.
11. Clarke NE. Arteriosclerosis, occlusive vascular disease and EDTA. Am J Cardiology 1960;2:233-6.
12. Meltzer LE. Chelation therapy. In: Seven MJ, Johnson LA, editors. Metal-binding in medicine. Philadelphia: JB Lippincott; 1960. p. 132-48.
13. Clarke NE Sr, Clarke NE Jr, Mosher RE. Treatment of occlusive vascular disease with disodium EDTA. Am J Med Sci 1960;239:732-44.
14. Kitchell JR, Meltzer LE, Seven MJ. Potential uses of chelation methods in the treatment of cardiovascular diseases. Prog Cardiovasc Dis 1961;3:338-49.
15. Boyle AJ, Clarke NE, Mosher RE, McCann DS. Chelation therapy in circulatory and sclerosing diseases. Fed Proc 1961;29:243-51.
16. Meltzer LE, Kitchell JR, Palmon F. The long-term use, side-effects, and toxicity of disodium EDTA. Am J Med Sci 1961;245:51-7.
17. Kitchell JR, Palmon F, Ayton N, Meltzer LE. The treatment of coronary artery disease with disodium EDTA. Am J Cardiol 1963;11:501-6.
18. Lamar CP. Chelation therapy of occlusive arteriosclerosis in diabetic patients. Angiology 1964;15:379-94.
19. Lamar CP. Chelation endarterectomy for occlusive atherosclerosis. J Am Geriatr Soc 1966;14:272-94.
20. Evers R. Chelation of vascular atheromatous disease (experience with 3000 patients). Laguna Hills (CA): American College for Advancement in Medicine; 1979.
21. The American Academy of Medical Preventics. Chelation therapy. Med Lett 1981;23:51.
22. Casdorph MR. EDTA chelation therapy, efficacy in arteriosclerotic disease. J Holistic Med 1981;3:53-9.
23. Robinson DM. Chelation therapy. NZ Med J 1982;95:750.
24. Olszewer E, Carter JP. EDTA chelation therapy in chronic degenerative disease. Med Hypothesis 1988;4:91-5.
25. McGillen MJ, Mancini GBJ. Inefficacy of EDTA chelation therapy for coronary atherosclerosis. N Engl J Med 1988;318:1618-9.
26. Winebaugh SR, Geraets DR. Apparent failure of edetic acid chelation therapy for the treatment of coronary atherosclerosis. DICP Ann Pharmacother 1990;24:22-5.
27. Deycher GP. Antioxidant therapy in the ageing process. In: Emerit I, Charles B, editors. Free radicals in aging. Basel: Birkauser Verlag; 1992. p. 93-117.
28. Hancke C, Flytlie K. Manipulation with EDTA. Ugeskar Laeger 1992;154:2213-5.
29. Hancke C, Flytlie K. Benefits of EDTA chelation therapy in arteriosclerosis: a retrospective study of 470 patients. J Advancement Med 1993;6:161-71.
30. Hopf R, Gleußner M, Babej-Dölle R, et al. Wirksamkeit von chelat bei patienten mit koronarer herzkrankheit [abstract]. Z Kardiol 1997;76(suppl 2):31.
31. Dimond EG, Kittle CF, Crockett JE. Comparison of internal mammary ligation and sham operation for angina pectoris. Am J Cardiol 1960;5:483-6.
32. Chappell LT, Wilson J. Chelation therapy for vascular disease. Dallas: American Heart Association; 1999. p. 164.
33. Anonymous. Chelation therapy. JAMA 1983;250:672.
34. Peterson GR. Adverse effects of chelation therapy. JAMA 1983;250:2926.
35. Meyer FP. Über die omnipotenz der chelattherapie. Forschende Komplementär 1998;5:226-71.
36. Magee R. Chelation treatment of atherosclerosis. Med J Aust 1985;142:514-5.
37. Haskell WL, Luskin FM, Marvasti FF. Complementary/alternative therapies in general medicine: cardiovascular disease. In: Complementary/alternative medicine, an evidence-based approach. Spencer JW, Jacobs JJ, editors. St Louis (MO): Mosby; 1999. p. 94.